Evidence map›Paper›PMID 39325698›Full record

ArticleChemistry (Weinheim an der Bergstrasse, Germany)2024

A Cycloparaphenylene Acetylene as Potential Precursor for an Armchair Carbon Nanotube.

Eric Sidler, Ramon Röthlisberger, Marcel Mayor

Abstract read
In one paragraph

Article in Chemistry (Weinheim an der Bergstrasse, Germany), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Eric SidlerDepartment of Chemistry, University of Basel, St. Johanns-Ring 19, 4056, Basel, Switzerland.ORCID https://orcid.org/0000-0001-7740-3869
Ramon RöthlisbergerDepartment of Chemistry, University of Basel, St. Johanns-Ring 19, 4056, Basel, Switzerland.
Marcel MayorDepartment of Chemistry, University of Basel, St. Johanns-Ring 19, 4056, Basel, Switzerland.ORCID https://orcid.org/0000-0002-8094-7813

Funding

Higher Education Discipline Innovation Project 90002-18011002Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung 200020-178808
6 · The paper itself

Abstract

The bottom-up synthesis of carbon nanotubes (CNTs) is a long-standing goal in synthetic chemistry. Producing CNTs with defined lengths and diameters would render these materials and thus their fascinating properties accessible in a controlled way. Inspired by a recently reported synthesis of armchair graphene sheets that relied on a benzannulation and Scholl oxidation of a poly(p-phenylene ethynylene), the same strategy is applied on a cyclic substrate with a short, but well defined CNT as target structure. Herein we report the synthesis of a derivatized [12]cycloparaphenylene acetylene ([12]CPPA) that was accessible employing a Sonogashira macrocyclization. The obtained macrocycle is the largest [n]CPPA reported to date and displays bright turquoise fluorescence with a large quantum yield of 77 %. The [12]CPPA can be transformed by a 12-fold benzannulation that converts each alkyne to a naphthalene and therefore allows formation of an armchair [12,12]CNT precursor. The final 72-fold Scholl oxidation to the [12,12]CNT turned out to be challenging and its optimization requires an improved synthetic strategy to produce large quantities of the final precursor. The developed approach poses a potential break through strategy for the production of CNTs and certainly incentivizes synthetic chemists to apply the same methodology for various conjugated macrocycles.

Indexed as

Carbon nanotubeCycloparaphenylene acetyleneMacrocycleNanohoopPolyaromatic hydrocarbon

Identifiers

PMID39325698
PMCPMC11632400

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.